ICAM1 and neoplasm: Intercellular adhesion molecule 1 (ICAM-1), for example, promotes the aggregation and retention of T cells in the tumor niche by binding to the β2-integrin LFA-1 in the melanoma xenograft model, which leads to improved immune control and potentially limits tumor development [18].